Added to YB: 2025-10-22
Pitch date: 2025-10-20
SIGA [neutral]
SIGA Technologies, Inc.
-23.82%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
Market Cap
$594.3M
Pitch Price
$8.48
Price Target
N/A
Dividend
7.23%
EV/EBITDA
4.04
P/E
7.28
EV/Sales
2.30
Sector
Pharmaceuticals
Category
special_situation
Monday Delight: 20/10/25 - SIGA Technologies, Inc.
SIGA (quick overview): Biotech focused on antiviral therapeutics & biodefense, notably TPOXX for smallpox. 48% ROIC, 4.1x EV/EBIT, $593M mkt cap. Majority revenue from US gov contract expiring Q4 2025 - renewal uncertain amid healthcare spending debates. Event-driven opportunity for investors with strong Washington political/budget views.
Read full article (1 min)